Prof Richard Warren BSc (Hons), MBChB (Hons), MRCP, PhD


View graph of relations


Richard Warren is Professor of Dermatology and Therapeutics and Honorary Consultant Dermatologist. He graduated from Liverpool University with a first class honours degree in Pharmacology and gained his Medical degree, with honours, one year later. He was awarded The J Hill Abram prize - highest mark in Medicine and the Reginald Dora Goodrick prize - highest mark in Surgery. His work in Dermatology has focussed on: pharmacogenetics (forming the basis of his PhD thesis), the genetic susceptibility to psoriasis and more recently biological therapies and their use in the treatment of psoriasis. For his work into the pharmacogenetics of methotrexate he has received national and international awards from the British Association of Dermatologists (BAD) and American Academy of Dermatology.  He is widely published in the field of Dermatology with numerous abstracts, papers and book contributions including The Lancet, Nature Genetics and The Journal of Investigative Dermatology. He is currently the EU Editor in Chief for the journal Dermatology and Therapy.  He has been an invited plenary speaker at major national and international dermatology meetings and is a member of The International Psoriasis Council. He currently chairs the BAD guideline group for methotrexate and is a member of the BAD biologics committee and research subcommittee. In 2012 he was the expert panel member on the National Institute for Health and Clinical Excellence guideline group for psoriasis.  He is co-lead of one of the two workstreams involved in the successful funding from the Medical Research Council stratified medicine grant  (Value £7 million) - Psoriasis Stratification to Optimise Relevant Therapies (PSORT).  He is the Chief Investigator on the largest psoriasis study currently running in the UK, known as SIGNATURE, investigating a new biological therapy for the treatment of severe psoriasis. He is the principle investigator at Salford Royal NHS Foundation Trust for BADBIR, a large scale pharamcovigilance study, and led the team to the award for highest recruiting centre in 2012.  He co-established a clinic for patients with severe psoriasis and psoriatic arthritis in 2010 with Dr Hector Chinoy which has received wide acclaim and is used as a national exemplar.

Research Beacons, Institutes and Platforms


  • dermatology, Pharmacology, psoriasis

Sustainable Development Goals

Related information